Individualized medication, medication "vary from person to person" , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.
This report contains market size and forecasts of Personalized Medicine in Global, including the following market information:
Global Personalized Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Personalized Medicine market was valued at 266890 million in 2021 and is projected to reach US$ 532910 million by 2028, at a CAGR of 10.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Personalized Medicine Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Personalized Medicine include Abbott Laboratories, Agilent Technologies, Amgen, Astellas Pharma, Astrazeneca, Bayer AG, Celgene Corporation, Glaxosmithkline Plc and Illumina, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Personalized Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Personalized Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Personalized Medicine Market Segment Percentages, by Type, 2021 (%)
Personalized Medicine Diagnostics
Personalized Medical Care
Personalized Medicine Therapeutics
Personalized Nutrition and Wellness
Global Personalized Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Personalized Medicine Market Segment Percentages, by Application, 2021 (%)
Oncology
Central Nervous System (CNS)
Immunology
Respiratory
Other Applications
Global Personalized Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Personalized Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Personalized Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Personalized Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agilent Technologies
Amgen
Astellas Pharma
Astrazeneca
Bayer AG
Celgene Corporation
Glaxosmithkline Plc
Illumina
Johnson & Johnson
Laboratory Corporation
Merck
Novartis AG
Roche Holding AG
Siemens AG
Takeda Pharmaceutical Company Limited